ACH Accendra Health, Inc.
XNYS
1.62
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $0.19 – $4.69
- YTD
- -29.96%
- Straddle Price
- $1.77
- P/C Vol Ratio
- 0.24
- Market Cap
- $0.0B
- Open
- $0.21
- Day Range
- $0.20 – $0.21
- Volume
- 30,069
- Prev Close
- $0.20
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.96% |
| Beta vs SPY | 1.08 |
| Cost of Equity (CAPM) | 10.90% (VRP-adj) |
| WACC | 5.30% |
| Volatility Risk Premium | +247.9pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +3.0% |
| DCF Horizon | 5 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.03 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $-0.3B |
| Return on Equity (TTM) | 54.8% |
| Book / Price | -2979.2% |
| Gross Margin (TTM) | 46.0% |
| FCF Margin (TTM) | -12.4% |
| Quality Score | 1/6 — cyclical/struggling (5y DCF) |
| SMA 50 | $0.79 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $0.37 |
| Bollinger Width / SMA20 | 39624.6% (drives anchor stability) |
| Net Debt | $1.2B |
| Market Cap | $0B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | median 35.6× · 8 peers |
| Peer EV/EBITDA | n/a | 0% | median 25.8× · 8 peers |
| Peer P/B | n/a | 0% | median 7.5× · 8 peers |
| Peer P/S | $287.79 | 15% | median 7.9× · 8 peers |
| Market Anchor (SMA50) | $0.79 | 85% | stability 85% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |
- Industry (SIC)
- WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES (5047) · industry map
- Exchange
- XNYS
- Market Cap
- $0.0B
- Employees
- 6,500
- List Date
- 1973-01-02
- CIK
- 0000075252
- Next Earnings
- 2026-11-05 (After-Close)
- EPS Forecast
- ($0.04) (3 est.)
- Headquarters
- Glen Allen, VA
- Homepage
- https://www.accendrahealth.com
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The comp…
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '26 | Avg |
|---|---|---|---|---|
| Jan | -15.47% | -8.66% | -4.74% | -9.62% |
| Feb | 56.35% | 30.85% | 6.61% | 31.27% |
| Mar | -15.30% | -20.67% | -2.98% | -12.98% |
| Apr | 22.64% | -24.95% | 49.60% | 15.76% |
| May | 10.72% | -3.71% | -24.06% | -5.68% |
| Jun | 0.96% | -15.09% | 23.47% | 3.11% |
| Jul | 3.21% | -2.62% | -12.96% | -4.12% |
| Aug | 20.51% | 1.22% | -64.52% | -14.26% |
| Sep | 7.11% | 0.00% | -51.07% | -14.65% |
| Oct | -19.44% | -- | -63.36%* | -41.40% |
| Nov | -18.02% | -- | -- | -18.02% |
| Dec | 14.51% | -- | -- | 14.51% |
| Total | 54.61% | -42.65% | -92.35% | -26.80% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Click Frenzy-Pro™ for an AI analysis of this ticker.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-02-24 | After-Close | 15.04% | 7.60% | 0.51x | Within |
| 2021-05-05 | After-Close | 13.01% | 5.00% | 0.38x | Within |
| 2021-08-03 | After-Close | 2.76% | 0.07% | 0.03x | Within |
| 2021-11-03 | After-Close | 7.68% | 2.02% | 0.26x | Within |
| 2022-02-23 | After-Close | 5.03% | 1.72% | 0.34x | Within |
| 2026-02-19 | After-Close | 17.14% | 5.24% | 0.31x | Within |
| 2026-05-11 | Pre-Market | 63.55% | 8.66% | 0.14x | Within |
| 2026-08-10 | After-Close | 87.50% | 10.00% | 0.11x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
ACH Options Activity & IV Rank
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 23rd percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 206
Period: 252 trading days
Above average volatility - stock moves with market amplification
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $1.3M | #3373 of 6285 | +64.4% | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $1.1M | #2259 of 3138 | +2.0% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $691K | #3057 of 3716 | -57.5% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $3K | #4342 of 4729 | -2.1% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
ACH Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Jane Street Group, LLC Custodian | $1.83M | 30.16% | 2026-06-30 |
| 2 | Susquehanna International Group, LLP Custodian | $1.58M | 25.91% | 2026-06-30 |
| 3 | Citadel Advisors LLC Custodian | $1.19M | 19.60% | 2026-06-30 |
| 4 | GROUP ONE TRADING LLC Custodian | $592.00K | 9.74% | 2026-06-30 |
| 5 | IMC-Chicago, LLC Custodian | $418.27K | 6.88% | 2026-06-30 |
| 6 | Simplex Trading, LLC Custodian | $173.74K | 2.86% | 2026-06-30 |
| 7 | Wolverine Trading, LLC Custodian | $153.04K | 2.52% | 2025-09-30 |
| 8 | Walleye Capital LLC | $141.59K | 2.33% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $79.00K | 34.08% | 2026-06-30 |
| 2 | Wolverine Trading, LLC Custodian | $59.44K | 25.64% | 2025-09-30 |
| 3 | IMC-Chicago, LLC Custodian | $47.20K | 20.36% | 2026-06-30 |
| 4 | Citadel Advisors LLC Custodian | $45.83K | 19.77% | 2026-06-30 |
| 5 | Simplex Trading, LLC Custodian | $342 | 0.15% | 2026-06-30 |
ACH Insider Trading (Form 4)
Latest: 2026-10-06| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Kenneth Gardner-Smith | President & CEO | Award (A) | +283,554 | — | EDGAR | |
| 2026-09-24 | Jonathan A Leon | EVP & CFO | Tax (F) | −4,265 | $0.85 | -$3.6K | EDGAR |
| 2026-05-20 | Heath H Galloway | EVP,General Counsel & CorpSecy | Tax (F) | −1,822 | $2.91 | -$5.3K | EDGAR |
| 2026-05-19 | Edward A Pesicka | President & CEO | Tax (F) | −17,692 | $3.04 | -$53.8K | EDGAR |
| 2026-05-19 | Jonathan A Leon | EVP & CFO | Tax (F) | −1,770 | $3.04 | -$5.4K | EDGAR |
| 2026-05-19 | Perry A Bernocchi | EVP, Chief Operating Officer | Tax (F) | −7,908 | $3.04 | -$24.0K | EDGAR |
| 2026-05-19 | Heath H Galloway | EVP,General Counsel & CorpSecy | Tax (F) | −966 | $3.04 | -$2.9K | EDGAR |
| 2026-05-18 | Mark A Beck | Director | Award (A) | +31,191 | — | EDGAR | |
| 2026-05-18 | Kenneth Gardner-Smith | Director | Award (A) | +31,191 | — | EDGAR | |
| 2026-05-18 | Gwendolyn M Bingham | Director | Grant (A) | +31,191 RSU | — | EDGAR | |
| 2026-05-18 | Teresa L. Kline | Director | Award (A) | +31,191 | — | EDGAR | |
| 2026-05-18 | Stephen W Klemash | Director | Award (A) | +31,191 | — | EDGAR | |
| 2026-03-24 | Jonathan A Leon | EVP & CFO | Tax (F) | −11,286 | $2.03 | -$22.9K | EDGAR |
| 2026-03-24 | Edward A Pesicka | President & CEO | Tax (F) | −58,945 | $2.03 | -$119.7K | EDGAR |
| 2026-03-24 | Perry A Bernocchi | EVP, Chief Operating Officer | Tax (F) | −20,841 | $2.03 | -$42.3K | EDGAR |
ACH Insider Holdings
8 insiders · @ $0.21| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Edward A Pesicka | President & CEO | 1,072,785 | $225.1K | $0 | 2 | 2026-05-19 |
| 2 | Kenneth Gardner-Smith | President & CEO | 369,667 | $77.6K | $0 | 2 | 2026-10-06 |
| 3 | Perry A Bernocchi | EVP, Chief Operating Officer | 313,913 | $65.9K | $0 | 3 | 2026-05-19 |
| 4 | Jonathan A Leon | EVP & CFO | 286,268 | $60.1K | $0 | 4 | 2026-09-24 |
| 5 | Heath H Galloway | EVP,General Counsel & CorpSecy | 166,306 | $34.9K | $0 | 4 | 2026-05-20 |
| 6 | Stephen W Klemash | Director | 90,242 | $18.9K | $0 | 1 | 2026-05-18 |
| 7 | Teresa L. Kline | Director | 85,316 | $17.9K | $0 | 1 | 2026-05-18 |
| 8 | Mark A Beck | Director | 71,259 | $15.0K | $0 | 1 | 2026-05-18 |
ACH Board & Officers
As of SEC filings through Oct 6, 2026Directors 9
- Edward A Pesicka · since Mar 7, 2019
- Mark A Beck · since Aug 7, 2019
- Robert J Henkel · since Oct 1, 2019
- Gwendolyn M Bingham · since Mar 5, 2020
- Stephen W Klemash · since Mar 1, 2021
- Kenneth Gardner-Smith · since Mar 1, 2022
- Rita Johnson-Mills · since Jun 1, 2022
- Teresa L. Kline · since Jun 1, 2022
- Carissa Rollins · since Jul 12, 2022
Officers 5
- Kenneth Gardner-Smith · President & CEO · listed since Oct 2026
- Jonathan A Leon · EVP & CFO · listed since Sep 2024
- Perry A Bernocchi · EVP, Chief Operating Officer · listed since Mar 2026
- Heath H Galloway · EVP,General Counsel & CorpSecy · since May 17, 2023
- Jennifer A Stone · EVP, CHRO · since Jun 3, 2024
10% owners 5
- Adam Gray · since Feb 28, 2025
- Christopher S Shackelton · since Feb 28, 2025
- Coliseum Capital Management, LLC (entity) · since Feb 28, 2025
- Coliseum Capital Partners, L.p. (entity) · since Feb 28, 2025
- Coliseum Capital, LLC (entity) · since Feb 28, 2025
Changes in the last 10 years (62)
| Oct 6, 2026 | Kenneth Gardner-Smith first listed as President & CEO in an SEC filing |
| Aug 10, 2026 | The company announced the departure of Edward A Pesicka as President & CEO in an SEC filing |
| Mar 10, 2026 | Perry A Bernocchi listed as EVP, Chief Operating Officer (previously EVP, CEO,. Patient Direct) in SEC filings |
| Dec 24, 2025 | The company announced the departure of Michael Wayne Lowry as SVP, Corporate Controller in an SEC filing |
| Dec 24, 2025 | The company announced the departure of Andrew G Long as EVP, CEO P&hs in an SEC filing |
| Sep 15, 2025 | The company announced the departure of Snehashish Sarkar as EVP, Chief Information Officer in an SEC filing |
| Feb 28, 2025 | Coliseum Capital, LLC became a 10% owner |
| Feb 28, 2025 | Coliseum Capital Partners, L.p. became a 10% owner |
| Feb 28, 2025 | Coliseum Capital Management, LLC became a 10% owner |
| Feb 28, 2025 | Christopher S Shackelton became a 10% owner |
| Feb 28, 2025 | Adam Gray became a 10% owner |
| Sep 24, 2024 | Jonathan A Leon listed as EVP & CFO (previously SVP, Corporate Treasurer) in SEC filings |
| Jun 21, 2024 | The company announced the departure of Alexander J Bruni as EVP, CFO in an SEC filing |
| Jun 5, 2024 | Snehashish Sarkar first listed as EVP, Chief Information Officer in an SEC filing |
| Jun 3, 2024 | Jennifer A Stone became EVP, CHRO |
| Apr 16, 2024 | The company announced the departure of Daniel J Starck as EVP, Business Excellence in an SEC filing |
| May 17, 2023 | Heath H Galloway became EVP,General Counsel & CorpSecy |
| Apr 13, 2023 | The company announced the departure of Nicholas J Pace as EVP, General Counsel in an SEC filing |
| Mar 3, 2023 | Daniel J Starck first listed as EVP, Business Excellence in an SEC filing |
| Mar 1, 2023 | Perry A Bernocchi became EVP, CEO,. Patient Direct |
| Nov 14, 2022 | Andrew G Long listed as EVP, CEO P&hs (previously EVP, CFO) in SEC filings |
| Oct 12, 2022 | The company announced the departure of Jeffrey T Jochims as EVP, Chief Operating Officer in an SEC filing |
| Oct 12, 2022 | Alexander J Bruni became EVP, CFO |
| Jul 12, 2022 | The company announced the departure of Mark F McGettrick from the board in an SEC filing |
| Jul 12, 2022 | Carissa Rollins became a director |
| Jul 11, 2022 | Tammy L Gomez became EVP, CHRO |
| Jun 1, 2022 | Teresa L. Kline became a director |
| Jun 1, 2022 | Rita Johnson-Mills became a director |
| Apr 4, 2022 | Christopher M Lowery reported in an SEC filing no longer being President, Global Products |
| Mar 1, 2022 | Kenneth Gardner-Smith became a director |
| Dec 15, 2021 | The company announced the departure of Michael C Riordan from the board in an SEC filing |
| Mar 1, 2021 | Stephen W Klemash became a director |
| Mar 1, 2021 | Aster Angagaw became a director |
| Apr 20, 2020 | Jeffrey T Jochims listed as EVP, Chief Operating Officer (previously EVP, Strategy & Solutions) in SEC filings |
| Mar 5, 2020 | Gwendolyn M Bingham became a director |
| Jan 2, 2020 | Anne M Whittemore reported in an SEC filing no longer being a director |
| Dec 5, 2019 | Michael C Riordan became a director |
| Nov 11, 2019 | Andrew G Long became EVP, CFO |
| Nov 1, 2019 | Mark P Zacur became EVP, Chief Commercial Officer |
| Oct 1, 2019 | Robert J Henkel became a director |
| Aug 7, 2019 | Mark A Beck became a director |
| Apr 8, 2019 | Jeffrey T Jochims became EVP, Strategy & Solutions |
| Mar 18, 2019 | Robert C Sledd no longer listed as Interim President & CEO in SEC filings |
| Mar 7, 2019 | Edward A Pesicka became a director |
| Mar 7, 2019 | Edward A Pesicka became President & CEO |
| Feb 7, 2019 | Robert K Snead listed as EVP, CFO (previously Interim CFO) in SEC filings |
| Dec 10, 2018 | Joseph S Pekala became SVP, Chief Information Officer |
| Nov 8, 2018 | Robert C Sledd first listed as Interim President & CEO in an SEC filing |
| Jun 25, 2018 | Timothy P Connolly became EVP, Operations & Supply Chain |
| Jun 1, 2018 | Robert K Snead became Interim CFO |
| May 18, 2018 | Michael Wayne Lowry first listed as SVP, Corporate Controller in an SEC filing |
| May 8, 2018 | Jonathan A Leon became SVP, Corporate Treasurer |
| Mar 26, 2018 | Shana Carol Neal became Chief Human Resources Officer |
| Mar 1, 2018 | Mark F McGettrick became a director |
| Feb 12, 2018 | Stuart Raymond Morris-Hipkins listed as President (previously EVP) in SEC filings |
| Feb 6, 2018 | Charles C Colpo listed as SVP, Strategic Supplier Mgmt (previously SVP, Owens & Minor Europe Ops) in SEC filings |
| Feb 2, 2018 | Nicholas J Pace listed as EVP, General Counsel (previously SVP, General Counsel) in SEC filings |
| Jan 3, 2018 | Christopher M Lowery became President, Global Products |
| Mar 13, 2017 | Stuart Raymond Morris-Hipkins became EVP |
| Feb 9, 2017 | Barbara B Hill became a director |
| Feb 7, 2017 | Erika T Davis listed as SVP, Chief Administr. Officer (previously SVP, Chief of Staff) in SEC filings |
| Nov 29, 2016 | Charles C Colpo listed as SVP, Owens & Minor Europe Ops (previously SVP, Strategic Relationships) in SEC filings |
- Prev
- 1
Not reported recently (26)
- Tammy L Gomez · Last reported as EVP, CHRO in an SEC filing dated Aug 16, 2023
- Shana Carol Neal · Last reported as Chief Human Resources Officer in an SEC filing dated Mar 7, 2022
- Mark P Zacur · Last reported as EVP, Chief Commercial Officer in an SEC filing dated Jun 7, 2021
- Aster Angagaw · Last reported as a director in an SEC filing dated May 3, 2021
- Eddie N Moore Jr · Last reported as a director in an SEC filing dated Apr 2, 2021
- Robert C Sledd · Last reported as a director in an SEC filing dated Mar 2, 2021
- Joseph S Pekala · Last reported as SVP, Chief Information Officer in an SEC filing dated Dec 11, 2019
- Stuart Essig · Last reported as a director in an SEC filing dated Jul 2, 2019
- Barbara B Hill · Last reported as a director in an SEC filing dated Jul 2, 2019
- Robert K Snead · Last reported as EVP, CFO in an SEC filing dated May 20, 2019
- Lemuel E Lewis · Last reported as a director in an SEC filing dated Apr 2, 2019
- Stuart Raymond Morris-Hipkins · Last reported as President in an SEC filing dated Mar 14, 2019
- Charles C Colpo · Last reported as SVP, Strategic Supplier Mgmt in an SEC filing dated Mar 6, 2019
- Erika T Davis · Last reported as SVP, Chief Administr. Officer in an SEC filing dated Mar 6, 2019
- Geoff Taylor Marlatt · Last reported as SVP, Manufacturer Services in an SEC filing dated Mar 6, 2019
- John W Gerdelman · Last reported as a director in an SEC filing dated Oct 2, 2018
- Paul Cody Phipps · Last reported as a director in an SEC filing dated Jul 3, 2018
- Timothy P Connolly · Last reported as EVP, Operations & Supply Chain in an SEC filing dated Jun 26, 2018
- Martha H. Marsh · Last reported as a director in an SEC filing dated May 18, 2018
- Rony Camil Kordahi · Last reported as EVP, North American Operations in an SEC filing dated Apr 5, 2018
- David S Simmons · Last reported as a director in an SEC filing dated Apr 2, 2018
- Richard A Meier · Last reported as EVP, Chief Financial Officer in an SEC filing dated Feb 12, 2018
- Stephen Russell Olive · Last reported as SVP, Chief Information Officer in an SEC filing dated Feb 12, 2018
- James E Rogers · Last reported as a director in an SEC filing dated Jun 21, 2017
- Craig R Smith · Last reported as a director in an SEC filing dated May 3, 2017
- Michael Jay Romans · Last reported as SVP, Human Resources in an SEC filing dated Mar 1, 2017
ACH Proposed Insider Sales (Form 144)
Latest: 2026-09-11What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-09-11 | Coliseum Capital Management, LLC | 10% Stockholder | 10,726,759 | $11.58M | 2026-09-11 | JonesTrading Institutional Servi… | — | EDGAR |
| 2024-11-21 | Leon Jonathan A | Officer | 5,282 | $62.4K | 2024-11-21 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2024-11-18 | Sarkar Snehashish | Officer | 2,055 | $25.2K | 2024-11-18 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2024-09-20 | Bruni Alexander J | Former Officer | 3,384 | $53.9K | 2024-09-20 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2024-08-22 | Leon Jonathan A | Officer | 7,500 | $118.7K | 2024-08-22 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2024-08-16 | Bruni Alexander J | Former Officer | 635 | $10.2K | 2024-08-16 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2024-07-23 | Starck Daniel J | Former Officer | 23,183 | $389.3K | 2024-07-23 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2024-06-06 | Bernocchi Perry A | Officer | 20,015 | $350.0K | 2024-06-06 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2024-06-05 | Beck Mark A | Director | 9,344 | $161.2K | 2024-06-05 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2024-06-04 | Sarkar Snehashish | Officer | 9,980 | $172.9K | 2024-06-04 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | FNDA Schwab Fundamental U.S. Small Company ETF | Nport | 0.07% | $6.0M | — | 2026-05-31 |
| 2 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $1.2M | — | 2026-09-30 |
| 3 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.00% | $1.0M | — | 2026-05-31 |
| 4 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $468,881 | — | 2026-09-30 |
| 5 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.00% | $418,954 | $74.6B | 2026-10-23 |
| 6 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.00% | $235,672 | — | 2026-09-30 |
| 7 | SCHB Schwab U.S. Broad Market ETF | Nport | 0.00% | $174,012 | — | 2026-05-31 |
| 8 | IHYF Invesco High Yield Bond Factor ETF | Invesco | 0.10% | $161,435 | — | 2026-04-30 |
| 9 | IWN iShares Russell 2000 Value ETF | iShares (BlackRock) | 0.00% | $143,706 | $13.9B | 2026-10-23 |
| 10 | DFAT Dimensional US Targeted Value ETF | Dimensional | 0.00% | $112,981 | — | 2026-10-23 |
| 11 | DFSV Dimensional US Small Cap Value ETF | Dimensional | 0.00% | $110,029 | — | 2026-10-23 |
| 12 | VHT Vanguard Health Care ETF | Vanguard | 0.00% | $105,395 | — | 2026-09-30 |
| 13 | FNDB Schwab Fundamental U.S. Broad Market ETF | Nport | 0.01% | $86,245 | — | 2026-05-31 |
| 14 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.00% | $50,290 | $1.2B | 2026-10-23 |
| 15 | QIDX Indexperts Quality Earnings Focused ETF | Nport | 0.11% | $44,218 | — | 2026-07-31 |
| 16 | VTWV Vanguard Russell 2000 Value ETF | Vanguard | 0.00% | $37,349 | — | 2026-09-30 |
| 17 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.00% | $23,003 | $96.5B | 2026-10-23 |
| 18 | PRF Invesco RAFI US 1000 ETF | Invesco | 0.00% | $21,037 | — | 2026-10-24 |
| 19 | MSSM Morgan Stanley Pathway Small-Mid Cap Equity ETF | Nport | 0.00% | $7,892 | — | 2026-05-31 |
| 20 | RSSL Global X Russell 2000 ETF | Global X | 0.00% | $7,143 | — | 2026-10-26 |
| 21 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.00% | $5,298 | — | 2026-10-23 |
| 22 | IWV iShares Russell 3000 ETF | iShares (BlackRock) | 0.00% | $4,349 | $20.4B | 2026-10-23 |
| 23 | VTHR Vanguard Russell 3000 ETF | Vanguard | 0.00% | $3,631 | — | 2026-09-30 |
| 24 | ITWO ProShares Russell 2000 High Income ETF | ProShares | 0.00% | $836 | — | 2026-10-26 |
| 25 | URTY ProShares UltraPro Russell2000 | ProShares | 0.00% | $641 | — | 2026-10-26 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (1 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q1 '26 | 2026-03-31 | $627.78M | $-6.47M | $-0.08 | $-50.08M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.